Skip to main content

Table 1 PABAK values for each ARV – 2-level interpretation

From: Comparison of predicted susceptibility between genotype and virtual phenotype HIV drug resistance interpretation systems among treatment-naive HIV-infected patients in Asia: TASER-M cohort analysis

Drug class

Drug

Proportion observed agreement

PABAK

95%CI of PABAK

NNRTI

Efavirenz

0.94

0.88

(0.86 - 0.91)

 

Etravirine

0.99

0.97

(0.96 - 0.99)

 

Nevirapine

0.99

0.98

(0.97 - 0.99)

NRTI

Abacavir

0.99

0.97

(0.96 - 0.99)

 

Didanosine

0.99

0.97

(0.96 - 0.99)

 

Emtricitabine

1.00

1.00

(1.00 -1.00)

 

Lamivudine

1.00

1.00

(1.00 -1.00)

 

Stavudine

0.99

0.98

(0.97 - 0.99)

 

Tenofovir

1.00

0.99

(0.99 - 1.00)

 

Zidovudine

0.98

0.97

(0.95 - 0.98)

PI

Atazanavir/r

1.00

0.99

(0.99 - 1.00)

 

Darunavir/r

1.00

1.00

(1.00 - 1.00)

 

Lopinavir/r

1.00

1.00

(0.99 - 1.00)

 

Saquinavir/r

1.00

1.00

(0.99 - 1.00)

 

Tipranavir/r

1.00

1.00

(0.99 - 1.00)